secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2023-10-17T23:59:59+00:00
Accession:  0001683168-23-007207
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharma raises ~$2.4M via warrant exercise; issues new inducement warrants for 3.76M shares
--------------------------------------------------------------------------------

- Holder exercised Existing Warrants for 1,878,000 shares at reduced exercise price of $1.28 per share.
- Company issued Inducement Warrants to purchase up to 3,756,000 shares (200% of exercised shares).
- New warrants exercisable from six-month anniversary for five years, with a $1.28 strike price.
- Gross proceeds of about $2.4M; net proceeds to be used for general corporate purposes.
- Financial advisor A.G.P./Alliance Global Partners received $145,000 fee for the transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316823007207/0001683168-23-007207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316823007207/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-007207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer